Related Experiment Video
Updated: Jul 15, 2026

Isolation and Culture of Primary Synovial Macrophages and Fibroblasts from Murine Arthritis Tissue
Published on: February 24, 2023
Macrophages and their products in rheumatoid arthritis
Zoltán Szekanecz1, Alisa E Koch
1Division of Rheumatology, Third Department of Medicine, University of Debrecen Medical and Health Sciences Center, Debrecen, Hungary. szekanecz@iiibel.dote.hu
Purpose Of Review:
Macrophages differentiate from peripheral-blood monocytes. Both monocytes and synovial macrophages are key players in rheumatoid arthritis. These cells are involved in the initiation and perpetuation of inflammation, leukocyte adhesion and migration, matrix degradation and angiogenesis. Macrophages express adhesion molecules, chemokine receptors and other surface antigens. They also secrete a number of chemokines, cytokines, growth factors, proteases and other mediators.
Recent Findings:
Macrophage migration-inhibitory factor has drawn significant attention recently. This cytokine is involved in macrophage activation and cytokine production. Migration-inhibitory factor also regulates glucocorticoid sensitivity and may be a pathogenic link between rheumatoid arthritis and atherosclerosis. Novel macrophage-derived chemokines and chemokine receptors have been identified. Interleukin-10 may have several proinflammatory effects that may influence its action in rheumatoid arthritis. Several proteinases including cathepsin G are produced by macrophages during rheumatoid arthritis-associated inflammatory and angiogenic events. Antirheumatic drugs, imatinib, chemokine receptor inhibitors and other specific strategies may become included in the therapy of rheumatoid arthritis.
Summary:
Macrophages and their products are key players in the pathogenesis of rheumatoid arthritis and may be good therapeutic targets.
Insights
Macrophages are central to rheumatoid arthritis pathogenesis, driving inflammation and joint damage. Targeting these cells and their products offers promising new therapeutic strategies for rheumatoid arthritis.
Area of Science:
- Immunology
- Rheumatology
Background:
- Monocytes differentiate into macrophages, which are critical in rheumatoid arthritis (RA).
- Macrophages contribute to RA by promoting inflammation, leukocyte migration, matrix degradation, and angiogenesis.
- These cells express key surface molecules and secrete various inflammatory mediators.
Purpose of the Study:
- To review the role of macrophages and their products in rheumatoid arthritis pathogenesis.
- To highlight recent findings on macrophage-related factors in RA.
- To discuss potential therapeutic targets within macrophage pathways.
Main Methods:
- Review of current literature on macrophage biology in rheumatoid arthritis.
- Analysis of recent findings on specific macrophage products like MIF, chemokines, and cytokines.
- Evaluation of emerging therapeutic strategies targeting macrophages.
Main Results:
- Macrophage migration-inhibitory factor (MIF) is a key cytokine involved in macrophage activation and RA pathogenesis, potentially linking RA and atherosclerosis.
- Novel macrophage-derived chemokines and receptors have been identified.
- Interleukin-10 may have complex roles in RA, and proteinases like cathepsin G are implicated in RA-associated inflammation and angiogenesis.
Conclusions:
- Macrophages and their secreted products are integral to rheumatoid arthritis pathogenesis.
- These cells and their mediators represent promising therapeutic targets for rheumatoid arthritis treatment.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Chronic Inflammation: Introduction
Inflammation
Rheumatic Heart Disease I: Introduction
The JAK-STAT Signaling Pathway
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...